propranolol has been researched along with Anemia Neonatorum in 1 studies
Propranolol: A widely used non-cardioselective beta-adrenergic antagonist. Propranolol has been used for MYOCARDIAL INFARCTION; ARRHYTHMIA; ANGINA PECTORIS; HYPERTENSION; HYPERTHYROIDISM; MIGRAINE; PHEOCHROMOCYTOMA; and ANXIETY but adverse effects instigate replacement by newer drugs.
propranolol : A propanolamine that is propan-2-ol substituted by a propan-2-ylamino group at position 1 and a naphthalen-1-yloxy group at position 3.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Okuno, T | 1 |
| Tokuriki, S | 1 |
| Yoshino, T | 1 |
| Tanaka, N | 1 |
| Ohshima, Y | 1 |
1 other study available for propranolol and Anemia Neonatorum
| Article | Year |
|---|---|
Diffuse neonatal hemangiomatosis in a very low-birthweight infant treated with erythropoietin.
Topics: Adrenergic beta-Antagonists; Anemia, Neonatal; Erythropoietin; Gestational Age; Hemangioma; Humans; | 2015 |